BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12563618)

  • 1. History of L-carnitine: implications for renal disease.
    Matera M; Bellinghieri G; Costantino G; Santoro D; Calvani M; Savica V
    J Ren Nutr; 2003 Jan; 13(1):2-14. PubMed ID: 12563618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine and hemodialysis.
    Bellinghieri G; Santoro D; Calvani M; Mallamace A; Savica V
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S116-22. PubMed ID: 12612967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine metabolism in uremia.
    Guarnieri G; Situlin R; Biolo G
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S63-7. PubMed ID: 11576925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients.
    Bellinghieri G; Santoro D; Calvani M; Savica V
    J Ren Nutr; 2005 Jan; 15(1):13-7. PubMed ID: 15648000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine in maintenance hemodialysis patients.
    Guarnieri G
    J Ren Nutr; 2015 Mar; 25(2):169-75. PubMed ID: 25600394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2.
    Wagner CA; Lükewille U; Kaltenbach S; Moschen I; Bröer A; Risler T; Bröer S; Lang F
    Am J Physiol Renal Physiol; 2000 Sep; 279(3):F584-91. PubMed ID: 10966938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L carnitine in hemodialysis patients.
    Calò LA; Vertolli U; Davis PA; Savica V
    Hemodial Int; 2012 Jul; 16(3):428-34. PubMed ID: 22360675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine replacement in end-stage renal disease and hemodialysis.
    Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
    Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-carnitine in dialysis patients.
    Ahmad S
    Semin Dial; 2001; 14(3):209-17. PubMed ID: 11422928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic functions of L-carnitine and its effects as feed additive in horses. A review.
    Zeyner A; Harmeyer J
    Arch Tierernahr; 1999; 52(2):115-38. PubMed ID: 10548966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of l-carnitine for human health.
    Adeva-Andany MM; Calvo-Castro I; Fernández-Fernández C; Donapetry-García C; Pedre-Piñeiro AM
    IUBMB Life; 2017 Aug; 69(8):578-594. PubMed ID: 28653367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-carnitine supplementation in dialysis: treatment in quest of disease.
    Wasserstein AG
    Semin Dial; 2013; 26(1):11-5. PubMed ID: 23173999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carnitine - mitochondria and beyond].
    Nałęcz KA; Nałęcz MJ
    Postepy Biochem; 2016; 62(2):85-93. PubMed ID: 28132459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
    Tamai I
    Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
    Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
    Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine system in uremic patients: molecular and clinical aspects.
    Savica V; Calvani M; Benatti P; Santoro D; Monardo P; Peluso G; Bellinghieri G
    Semin Nephrol; 2004 Sep; 24(5):464-8. PubMed ID: 15490412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine supplementation in dialysis patients: does the evidence justify its use?
    Steinman TI
    Semin Dial; 2005; 18(1):1-2. PubMed ID: 15663752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.